reported that cell surface glypican-3 (GPC3) stimulates Wnt/β-catenin signaling in HCC by forming a complex with Wnt ligands via its heparan sulfate glycosaminoglycan (HSGAG) chains. The gene discussed is GPC3; the disease is hepatocellular carcinoma.